Spruce Biosciences Inc reports results for the quarter ended in June - Earnings Summary

Spruce Biosciences

14/08/2023 22:07

* Spruce Biosciences Inc  SPRB.OQ  reported a quarterly
adjusted
loss of 32 cents​​ per share for the quarter ended in June. The
mean expectation of six analysts for the quarter was for a loss
of 39 cents per share.
    * Revenue was $2.17 million​; analysts expected $816.67
thousand. 
    * Spruce Biosciences Inc's reported EPS for the quarter was
a loss
of 32 cents​.
    * The mean earnings estimate of analysts had fallen by
about 16.1%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Spruce Biosciences Inc shares had risen by 3.5% this
quarter and
gained 102.8% so far this year.
    * The company reported a quarterly loss of $12.82 million.
    * Wall Street's median 12-month price target for Spruce
Biosciences Inc is $8.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 14 at 09:06 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.39          -0.32          Beat
 Mar. 31 2023      -0.36          -0.40          Missed
 Dec. 31 2022      -0.53          -0.47          Beat
 Sep. 30 2022      -0.53          -0.48          Beat